Zeit | Aktuelle Nachrichten | Rating | Leser | ||
---|---|---|---|---|---|
Fr | Praxis Precision Medicines, Inc.: Praxis Precision Medicines Provides Update on Essential3 and Corporate Update | 98 | BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies... ► Artikel lesen | ||
Fr | Outlook Therapeutics, Inc.: Outlook Therapeutics Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration | 95 | ISELIN, N.J., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom... ► Artikel lesen | ||
Fr | Safe & Green Holdings Corp. Regains Compliance with Nasdaq Continued Listing Requirements | 97 | MIAMI, FL, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Safe & Green Holdings Corp. (NASDAQ: SGBX) ("Safe & Green Holdings" or the "Company"), a leading developer, designer, and fabricator of modular structures... ► Artikel lesen | ||
Fr | Nayax Ltd.: Nayax Announces the Acquisition of UPPay | 839 | HERZLIYA, Israel, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement and payments platform designed to help merchants scale their business by simplifying... ► Artikel lesen | ||
Fr | TapTravel Nordic AB (publ): Q4 Year-End Report TapTravel Nordic AB | 56 | Summary of the period October - December 2024• 2024 concludes with a temporary decline in booking volumes, driven by short-term budget constraints at a limited number of contracted government agencies.•... ► Artikel lesen | ||
Fr | Avance Gas Holding Ltd: Key information relating to extraordinary dividend of $0.75 per share | 848 | Hamilton, Bermuda. February 28, 2025Key information relating to the extraordinary dividend:Dividend: $0.75Declared currency: USDLast day including right: March 4, 2025Ex-date: March 5, 2025Record date:... ► Artikel lesen | ||
Fr | Novartis Pharma AG: Novartis oral Fabhalta (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G) | 250 | If approved, Fabhalta® will be the only medicine indicated to selectively target the underlying cause of C3G1, an ultra-rare, progressive kidney disease with no currently approved treatments2-5
Phase... ► Artikel lesen | ||
Fr | Avance Gas Holding Ltd: Closing of the sale of the MGC fleet and extraordinary dividend of $0.75 per share | 854 | Hamilton, Bermuda. February 28, 2025
Avance Gas Holding Ltd ("Avance Gas" or "Company") (OSE: AGAS) today announce closing of the sale of the Medium Sized Gas Carrier ("MGC") fleet to subsidiaries... ► Artikel lesen | ||
Fr | Krystal Biotech, Inc.: Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK for the Treatment of Dystrophic Epidermolysis Bullosa | 95 | PITTSBURGH, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ: KRYS), a commercial-stage biotechnology company, today welcomed the European Medicines Agency's (EMA's)... ► Artikel lesen | ||
Fr | ROCKWOOL A/S: Completion of conversion of A shares to B shares in accordance with the articles of association and information on adjusted number of voting rights and share capital | 191 | Company announcementfor ROCKWOOL A/SRelease no. 11 - 2025to Nasdaq Copenhagen 28 February 2025 Completion of conversion of A shares to B shares in accordance with the articles of association... ► Artikel lesen | ||
Fr | AGF Management Ltd.: AGF Investments Announces Proposed Fund and ETF Terminations | 289 | TORONTO, Feb. 28, 2025 (GLOBE NEWSWIRE) -- ETF Terminations AGF Investments Inc. (AGF Investments) today announced the proposed termination of AGF Systematic Global Multi-Sector Bond ETF (ticker:... ► Artikel lesen | ||
Fr | Apellis Pharmaceuticals, Inc.: Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results | 233 | Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growth SYFOVRE® (pegcetacoplan injection) full year 2024 net product revenue of $611.9 millionEMPAVELI® (pegcetacoplan)... ► Artikel lesen | ||
Fr | Achilles Therapeutics PLC: Achilles Therapeutics Announces Voluntary Nasdaq Delisting and SEC Deregistration | 179 | LONDON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL) (the Company) today announced that it has formally notified The Nasdaq Stock Market LLC (Nasdaq) of its intention to... ► Artikel lesen | ||
Fr | Traws Pharma, Inc.: Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule | 136 | NEWTOWN, Pa., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (Nasdaq: TRAW) ("Traws" or "Traws Pharma"), a clinical stage biopharmaceutical company developing oral small molecules for the treatment... ► Artikel lesen | ||
Fr | Xali Gold Corp.: Xali Gold Enters Option to Acquire Sarape Project Located Within Rio Sonora Valley, Mexico | 542 | VANCOUVER, British Columbia, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Xali Gold Corp. (TSXV:XGC) ("Xali Gold" or the "Company") is pleased to announce it has entered into a binding Letter of Intent ("LOI")... ► Artikel lesen | ||
Fr | CompoSecure, Inc.: CompoSecure Announces Completion of Spin-Off of Resolute Holdings | 211 | SOMERSET, N.J., and NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO) ("CompoSecure"), a leader in metal payment cards, security, and authentication solutions, today announced... ► Artikel lesen | ||
Fr | Abacus Mining and Exploration Corp.: Abacus Announces Financing | 72 | VANCOUVER, British Columbia, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Abacus Mining & Exploration Corporation ("Abacus" or the "Company") (TSXV: AME) is pleased to announce a non-brokered private placement... ► Artikel lesen | ||
Fr | OTC Markets Group Welcomes White Pearl Technology Group AB to OTCQX | 122 | NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced White Pearl Technology... ► Artikel lesen | ||
Fr | Boralex Inc.: Boralex reports net earnings of $74 million for fiscal 2024 and continues construction of its large-scale projects in Québec, Ontario and the United Kingdom | 75 | MONTREAL, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Boralex Inc. ("Boralex" or the "Corporation") (TSX: BLX) is pleased to report its results for the three-month period and year ended December 31, 2024. HighlightsFinancial... ► Artikel lesen | ||
Fr | Akero Therapeutics Inc.: Akero Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update | 89 | -- Reported unprecedented, statistically significant reversal of compensated cirrhosis (F4) due to MASH after 96 weeks of treatment with efruxifermin (EFX) in Phase 2b SYMMETRY study -- -- Completed... ► Artikel lesen | ||
Fr | TeraWulf Inc.: TeraWulf Reports Fourth Quarter and Full Year 2024 Results | 423 | Announced strategic expansion into AI-driven HPC hosting with long-term data center leases expected to generate $1 billion in cumulative revenue over initial 10-year contract terms Annual revenue... ► Artikel lesen | ||
Fr | Liveone, Inc.: LiveOne (Nasdaq: LVO) Surpasses 1 Million Subscribers, Including Tesla | 170 | - Combined paid and ad-supported subscribers up 100%+ since Jan. 1st - 900k+ or 45%+ of Tesla vehicles converted - 30%+ month-over-month increase in listening on Telly - B2B pipeline grows... ► Artikel lesen | ||
Fr | NewGenIVF Group Limited: NewGen Regains Compliance with Nasdaq Minimum Bid Price Requirement and Announces Listing Transfer to the Nasdaq Capital Market | 110 | BANGKOK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain... ► Artikel lesen | ||
Fr | Plug Power, Inc.: Plug Power Adopts Executive Compensation Program to Strengthen Leadership Alignment with Shareholders | 238 | LATHAM, N.Y., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a leading provider of hydrogen solutions, today announced the adoption of an executive compensation program that enables... ► Artikel lesen | ||
Fr | Regeneron Pharmaceuticals, Inc.: Linvoseltamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Multiple Myeloma | 576 | TARRYTOWN, N.Y., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human... ► Artikel lesen |